Page   1   of   5
                                                -----    ------
       SECURITIES AND EXCHANGE COMMISSION
             WASHINGTON, D.C. 20549

SCHEDULE 13G.  INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO 13D-1(B) AND AMENDMENTS THERETO FILED PURSUANT TO 13D-2(B)

                  SCHEDULE 13G

    Under the Securities Exchange Act of 1934
               (Amendment No. 1)*


               Cell Therapeutics
- -----------------------------------------------
                (Name of Issuer)


                 Common Stock
- -----------------------------------------------
         (Title of Class of Securities)



     Check the following box if a fee is being paid with this statement.  (A fee
is not required only if the filing person:  (1) has a previous statement on file
reporting  beneficial  ownership  of more  than  five  percent  of the  class of
securities  described  in Item 1;  and (2) has  filed  no  amendment  subsequent
thereto reporting  beneficial  ownership of five percent or less of such class.)
(See Rule 13d-7.) / /

     *The  remainder  of this cover  page  shall be filled  out for a  reporting
person's  initial  filing on this  form with  respect  to the  subject  class of
securities,  and for any subsequent amendment containing information which would
alter the disclosures provided in a prior page.

     The  information  required in the remainder of this cover page shall not be
deemed to be "filed"  for the purpose of Section 18 of the  Securities  Exchange
Act of 1934 ("Act") or otherwise  subject to the  liabilities of that section of
the Act but shall be subject to all other  provisions of the Act  (however,  see
Notes).

                                           Page   2   of   5
                                                -----    -------
CUSIP No. 150934107
                       13G

(1)  Names of Reporting  Persons.
     S.S. or I.R.S.  Identification  Nos. of Above Persons

            INVESCO Funds Group, Inc.
            IRS Number:  84-0235630

(2)  Check the Appropriate Box if a Member of a Group (See Instructions)
                                (a) / /
                                (b) / /

(3)  SEC Use Only

(4)  Citizenship or Place of Organization

     State of Delaware, USA

     Number of Shares        (5)   Sole Voting Power
     Beneficially                  0
     Owned by                (6)   Shared Voting Power
     Each Reporting                None
     Person With             (7)   Sole Dispositive Power
                                   0
                             (8)   Shared Dispositive Power
                                   None

(9)  Aggregate Amount Beneficially Owned by Each Reporting Person
     0

(10) Check if the  Aggregate  Amount in Row (9)  Excludes  Certain  Shares
     (See Instructions)            / /

(11) Percent of Class Represented by Amount in Row (9)
     0.00%

(12) Type of Reporting Person (See Instructions)

     I.A.

                                          Page   3   of   5
                                               -----    ------

ITEM 1 (a)  NAME OF ISSUER:
              Cell Therapeutics

ITEM 1 (b)  ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
              201 Elliot Ave West
              Suite 400
              Seattle, WA 98119

ITEM 2 (a)  NAME OF PERSON(S) FILING:

              INVESCO Funds Group, Inc.

ITEM 2(b)   ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:

              4350 South Monaco Street
              Denver, CO  80237

ITEM 2 (c)  CITIZENSHIP:

              Organized under the laws by the State of Delaware, USA

ITEM 2 (d)  TITLE OF CLASS OF SECURITIES

              Common Stock

ITEM 2 (e)  CUSIP NUMBER:   150934107
                            ---------

ITEM 3 IF THIS STATEMENT IS FILED PURSUANT TO RULES 13D-1(B) OR 13D-2(B), CHECK
       WHETHER THE PERSON FILING IS A:

(a) / / Broker or Dealer registered under Section 15 of the Act.
(b) / / Bank as defined in Section 3(a)(6) of the Act.
(c) / / Insurance Company as defined in Section 3(a)(19) of the Act.
(d) / / Investment Company registered under Section 8 of the Investment
        Company Act.
(e) /X/ Investment Adviser registered under Section 203 of the Investment
        Advisers Act of 1940.
(f) / / Employee Benefit Plan, Pension Fund which is subject to provisions of
        Employee Retirement Income Security Act of 1974 or Endowment Fund; see
        Rule 13d-1(b)(1)(ii)(F).
(g) / / Parent Holding Company in accordance with Rule 13d-1(b)(ii)(G).
(h) / / A  savings  association  as  defined  in  Section  3(b) of the  Federal
        Deposit Insurance Act (12 U.S.C. 1813).
(i) / / A church plan that is excluded  from the  definition  of an  investment
        company under Section 3(c)(14) of the Investment Company Act of 1940
        (15 U.S.C. 80a-3).
(j) / / Group, in accordance with Rule 13d-1(b)(1)(ii)(J).

                                      Page   4   of   5
                                           -----    ---
ITEM 4 (a) - (c) OWNERSHIP:

The information in items 1 and 5-11 on the cover page (p 2) of this statement on
Schedule 13G is hereby incorporated by reference.

ITEM 5 OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS         / /
Not Applicable.

ITEM 6 OWNERSHIP  OF MORE THAN FIVE  PERCENT  ON BEHALF OF  ANOTHER  PERSON
Not Applicable.

ITEM 7 IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARIES WHICH
ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY:
Not Applicable.

ITEM 8 IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF A GROUP.
Not applicable.

ITEM 9 NOTICE OF DISSOLUTION OF GROUP.
Not applicable.

                                         Page   5   of   5
                                              -----    -------

ITEM 10 CERTIFICATION:

By signing  below,  I certify that, to the best of my knowledge and belief,  the
securities  referred to above were  acquired in the ordinary  course of business
and were not  acquired for the purpose of and do not have the effect of changing
or  influencing  the  control  of the  issuer  of such  securities  and were not
acquired in connection with or as a participant in any  transaction  having such
purposes or effect.

SIGNATURE


After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.


January 31, 2002
- ----------------------------------------
(Date)

/s/ Glen A. Payne
- ----------------------------------------
Glen A. Payne,
as General Counsel for
INVESCO Funds Group, Inc.